低收入和中等收入国家基于血浆的COVID-19治疗方法及输血传播感染风险
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections.
作者信息
Epstein Jay, Martin Smid W, Wendel Silvano, Somuah Daniel, Burnouf Thierry
机构信息
US Food and Drug Administration, Silver Spring, MD, USA.
Sanquin Consulting Services, Amsterdam, Academic Institute IDTM, Groningen, The Netherlands.
出版信息
NPJ Vaccines. 2020 Nov 3;5(1):103. doi: 10.1038/s41541-020-00256-6.
Abstract
Ethical principles should prevail in the collection, testing and use of COVID-19 convalescent plasma (CCP) for human research in low- and middle- income countries. To appropriately guarantee safety, only blood establishments that comply with recognized quality standards should collect CCP.
摘要
在低收入和中等收入国家，将新冠康复者血浆用于人体研究的采集、检测和使用过程中，伦理原则应占主导地位。为适当保障安全，只有符合公认质量标准的血液机构才能采集新冠康复者血浆。
相似文献
1
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections.低收入和中等收入国家基于血浆的COVID-19治疗方法及输血传播感染风险
NPJ Vaccines. 2020 Nov 3;5(1):103. doi: 10.1038/s41541-020-00256-6.
2
Access to safe blood in low-income and middle-income countries: lessons from India.低收入和中等收入国家安全血液的获取：来自印度的经验教训。
BMJ Glob Health. 2017 May 18;2(2):e000167. doi: 10.1136/bmjgh-2016-000167. eCollection 2017.
3
Transfusion-transmitted infections: existing and emerging pathogens.输血传播感染：现存及新出现的病原体
J Postgrad Med. 2005 Apr-Jun;51(2):146-51.
4
[Transfusion-transmitted protozoal infections: what is the risk in non-endemic countries?].[输血传播的原生动物感染：非流行国家的风险有哪些？]
Acta Med Port. 2011 Dec;24 Suppl 4:897-906. Epub 2011 Dec 31.
5
Safety of blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses.加勒比国家血液供应的安全性：筛查献血者乙肝和丙肝病毒标志物的作用。
J Clin Virol. 2005 Dec;34 Suppl 2:S75-80. doi: 10.1016/s1386-6532(05)80038-1.
6
European strategies against the parasite transfusion risk.欧洲应对寄生虫输血风险的策略。
Transfus Clin Biol. 2005 Feb;12(1):1-4. doi: 10.1016/j.tracli.2004.12.001.
7
The risk of transfusion-transmitted infections in sub-Saharan Africa.撒哈拉以南非洲地区经输血传播感染的风险。
Transfusion. 2010 Feb;50(2):433-42. doi: 10.1111/j.1537-2995.2009.002402.x. Epub 2009 Oct 15.
8
Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands.输血产品病原体灭活处理的发展：方法、当前应用及需求综述
Transfus Apher Sci. 2015 Feb;52(1):19-34. doi: 10.1016/j.transci.2014.12.016. Epub 2014 Dec 30.
9
Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.27 个高收入、中等收入和低收入国家（PURE）中女性和男性在风险因素、治疗方法、心血管疾病发病率和死亡率方面的差异：一项前瞻性队列研究。
Lancet. 2020 Jul 11;396(10244):97-109. doi: 10.1016/S0140-6736(20)30543-2. Epub 2020 May 20.
10
Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh.低收入、低感染率情况下女性的生殖道感染：孟加拉国马特拉布地区综合征管理评估
Lancet. 1999 Nov 20;354(9192):1776-81. doi: 10.1016/s0140-6736(99)02463-0.
引用本文的文献
1
Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19.针对新型冠状病毒的异源超免疫多克隆抗体：一种针对新冠病毒肺炎具有广泛覆盖、可负担且可扩展的潜在免疫疗法。
Front Med (Lausanne). 2021 Sep 6;8:743325. doi: 10.3389/fmed.2021.743325. eCollection 2021.
2
Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.康复期新冠病毒肺炎血浆治疗：回归基础与伦理，以及后续步骤
Transfus Clin Biol. 2021 Aug;28(3):225-227. doi: 10.1016/j.tracli.2021.07.005.
3
International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.新型冠状病毒肺炎康复者血浆采集与使用国际论坛：方案、挑战与经验教训：总结
Vox Sang. 2021 Nov;116(10):1117-1135. doi: 10.1111/vox.13113. Epub 2021 May 20.
本文引用的文献
1
Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic.在低收入和中等收入国家，基于血浆的新冠肺炎治疗方法存在引发艾滋病流行的高风险。
NPJ Vaccines. 2020 Jul 6;5:58. doi: 10.1038/s41541-020-0209-2. eCollection 2020.
2
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.COVID-19 恢复期血浆采购指南：高收入和中低收入国家之间的差异。
Vox Sang. 2021 Jan;116(1):18-35. doi: 10.1111/vox.12970. Epub 2020 Jul 20.
3
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety.新型冠状病毒肺炎康复者血浆在低收入和中等收入国家的应用：呼吁制定伦理原则并确保质量与安全
Vox Sang. 2021 Jan;116(1):13-14. doi: 10.1111/vox.12964. Epub 2020 Jun 24.
4
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma.新型冠状病毒肺炎康复者恢复期血浆制备及输注的注意事项。
Vox Sang. 2020 Aug;115(6):485-487. doi: 10.1111/vox.12939. Epub 2020 May 14.
5
Ebola: a call for blood transfusion strategy in sub-Saharan Africa.埃博拉：呼吁在撒哈拉以南非洲地区制定输血策略。
Lancet. 2014 Oct 11;384(9951):1347-8. doi: 10.1016/S0140-6736(14)61693-7. Epub 2014 Sep 29.
Zotero 插件